Market Perform price target of $66.00 (from $133.00)BMO Capital analyst, Alex Arfaei believes Valeant Pharmaceuticals (NYSE: VRX) management needs to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE